Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 33539742

PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2021 Feb
First author
Borchmann P

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2021 Feb;22(2):161-162. doi: 10.1016/S1470-2045(20)30640-9.
    note
    Source null
    related pmid
    33539737
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2021 May;22(5):e181. doi: 10.1016/S1470-2045(21)00146-7.
    note
    Source null
    related pmid
    33932378
    relationship
    Comment in
  3. citation
    Lancet Oncol. 2021 May;22(5):e182. doi: 10.1016/S1470-2045(21)00210-2.
    note
    Source null
    related pmid
    33932379
    relationship
    Comment in
  4. citation
    Strahlenther Onkol. 2021 Oct;197(10):946-949. doi: 10.1007/s00066-021-01826-w.
    note
    Source null
    related pmid
    34379136
    relationship
    Comment in

Authors and identifiers

  1. name
    Borchmann P
    type
    Author
  2. name
    Plütschow A
    type
    Author
  3. name
    Kobe C
    type
    Author
  4. name
    Greil R
    type
    Author
  5. name
    Meissner J
    type
    Author
  6. name
    Topp MS
    type
    Author
  7. name
    Ostermann H
    type
    Author
  8. name
    Dierlamm J
    type
    Author
  9. name
    Mohm J
    type
    Author
  10. name
    Thiemer J
    type
    Author
  11. name
    Sökler M
    type
    Author
  12. name
    Kerkhoff A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Borchmann P
    type
    Author
  2. name
    Plütschow A
    type
    Author
  3. name
    Kobe C
    type
    Author
  4. name
    Greil R
    type
    Author
  5. name
    Meissner J
    type
    Author
  6. name
    Topp MS
    type
    Author
  7. name
    Ostermann H
    type
    Author
  8. name
    Dierlamm J
    type
    Author
  9. name
    Mohm J
    type
    Author
  10. name
    Thiemer J
    type
    Author
  11. name
    Sökler M
    type
    Author
  12. name
    Kerkhoff A
    type
    Author
bibliography ids
  1. nci-bib-b8d9bba2ec9c0b88305a1762
book metadata
content sha256
ab0040dea326aea6924d0f54b761a8d219226cd462a28a5ae4c5e58714de0271
document type
citation
dois
  1. 10.1016/S1470-2045(20)30601-X
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:33539742
immutable id
pubmed:33539742@ab0040dea326aea6924d0f54b761a8d219226cd462a28a5ae4c5e58714de0271
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
2
name
The Lancet. Oncology
nlm unique id
100957246
pages
223-234
volume
22
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2021 Feb;22(2):161-162. doi: 10.1016/S1470-2045(20)30640-9.
    note
    Source null
    related pmid
    33539737
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2021 May;22(5):e181. doi: 10.1016/S1470-2045(21)00146-7.
    note
    Source null
    related pmid
    33932378
    relationship
    Comment in
  3. citation
    Lancet Oncol. 2021 May;22(5):e182. doi: 10.1016/S1470-2045(21)00210-2.
    note
    Source null
    related pmid
    33932379
    relationship
    Comment in
  4. citation
    Strahlenther Onkol. 2021 Oct;197(10):946-949. doi: 10.1007/s00066-021-01826-w.
    note
    Source null
    related pmid
    34379136
    relationship
    Comment in
outcomes validated
false
pmid
33539742
provenance
batch id
79f1021053e858d13ff3
provider
NCBI PubMed ESummary
record sha256
632ea1a432d369cb38f6144e98125ecc0635bb6a1c0d856516cb11dd0dae097f
response sha256
671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
retrieved at
2026-09-09T23:47:59.098265+00:00
publication date
display
2021 Feb
precision
month
year
2021
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
  6. Equivalence Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/33539742/
title
PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial.

Preserved source evidence · Not medical advice